☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Clinical
Sanofi Signs a Non-Exclusive Clinical Collaboration Agreement with Mirati to Evaluate Adagrasib + SAR442720 (RMC-4630) in P-I/II S...
October 8, 2021
BMS Expands its Collaboration with Compugen to Evaluate the Combination of COM701 + Opdivo
February 23, 2021
Zydus Cadila Seeks Approval to Commence P-III Clinical Study of ZyCoV-D
December 30, 2020
Pfizer and BioNTech's BNT162b2 Demonstrates 90% Efficacy in Preventing COVID-19
November 10, 2020
Celltrion Reports Results of CT-P59 in P-I Study for COVID-19
November 9, 2020
Thermo Fisher Expands its Direct-to-Patient Service Offerings
October 28, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.